Clinical trials
Phase 2 Pulmonary Fibrosis trials in Australia
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
12 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2007 | 1 |
| 2010 | 1 |
| 2013 | 1 |
| 2017 | 1 |
| 2020 | 1 |
| 2021 | 2 |
| 2022 | 1 |
| 2023 | 1 |
| 2024 | 2 |
| 2026 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 5 |
| Terminated | 4 |
| Active, not recruiting | 2 |
| Recruiting | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Boehringer Ingelheim | 2 |
| Endeavor Biomedicines, Inc. | 2 |
| Amgen | 1 |
| Avalyn Pharma Inc. | 1 |
| Bristol-Myers Squibb | 1 |
| Celgene | 1 |
| Contineum Therapeutics | 1 |
| Kyntra Bio | 1 |
| Pliant Therapeutics, Inc. | 1 |
| The University of Queensland | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Pulmonary Fibrosis | 12 |
| Idiopathic Pulmonary Fibrosis | 8 |
| Lung Diseases, Interstitial | 5 |
| Idiopathic Interstitial Pneumonias | 3 |
| Alveolitis, Extrinsic Allergic | 1 |
| Dyskeratosis Congenita | 1 |
| Fibrosis | 1 |
| Lung Diseases | 1 |
| Pathologic Processes | 1 |
| Respiratory Tract Diseases | 1 |
Trials
Showing 1 to 12 of 12. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.